- Home
- ARQQ vs TVGN Comparison
ARQQ vs TVGN Comparison
Compare ARQQ & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- TVGN
- Stock Information
- Founded
- ARQQ 2017
- TVGN 2020
- Country
- ARQQ United Kingdom
- TVGN United States
- Employees
- ARQQ N/A
- TVGN N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- TVGN Blank Checks
- Sector
- ARQQ Technology
- TVGN Finance
- Exchange
- ARQQ Nasdaq
- TVGN Nasdaq
- Market Cap
- ARQQ 51.8M
- TVGN 53.6M
- IPO Year
- ARQQ N/A
- TVGN N/A
- Fundamental
- Price
- ARQQ $10.65
- TVGN $1.64
- Analyst Decision
- ARQQ Strong Buy
- TVGN
- Analyst Count
- ARQQ 1
- TVGN 0
- Target Price
- ARQQ $50.00
- TVGN N/A
- AVG Volume (30 Days)
- ARQQ 212.7K
- TVGN 6.3M
- Earning Date
- ARQQ 12-03-2024
- TVGN 11-29-2024
- Dividend Yield
- ARQQ N/A
- TVGN N/A
- EPS Growth
- ARQQ N/A
- TVGN N/A
- EPS
- ARQQ N/A
- TVGN N/A
- Revenue
- ARQQ $740,000.00
- TVGN N/A
- Revenue This Year
- ARQQ $341.56
- TVGN N/A
- Revenue Next Year
- ARQQ $274.91
- TVGN N/A
- P/E Ratio
- ARQQ N/A
- TVGN N/A
- Revenue Growth
- ARQQ N/A
- TVGN N/A
- 52 Week Low
- ARQQ $3.72
- TVGN $0.26
- 52 Week High
- ARQQ $23.00
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- ARQQ 52.47
- TVGN 52.11
- Support Level
- ARQQ $7.00
- TVGN $1.26
- Resistance Level
- ARQQ $8.15
- TVGN $1.76
- Average True Range (ATR)
- ARQQ 1.09
- TVGN 0.33
- MACD
- ARQQ -0.05
- TVGN -0.07
- Stochastic Oscillator
- ARQQ 40.14
- TVGN 46.67
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology which makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. Arqit delivers its symmetric key agreement technology via its QuantumCloud. Its product, QuantumCloud, enables any device to download a lightweight software agent, which can create keys in partnership with any other device. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. Key revenue comes from the UK.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.